Citadel Advisors
ARRY

Citadel Advisors’s Array Biopharma Inc ARRY Stock Holding History

Citadel Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,346,050
Closed -$201M – 10178
2019
Q2 		$201M Buy
4,346,050
+3,792,085
+685% +$106M 0.09% 161
2019
Q1 		$13.5M Buy
553,965
+348,387
+169% +$7.25M 0.01% 1716
2018
Q4 		$2.93M Sell
205,578
-114,994
-36% -$1.74M ﹤0.01% 3552
2018
Q3 		$4.87M Buy
320,572
+86,480
+37% +$1.33M ﹤0.01% 3040
2018
Q2 		$3.93M Sell
234,092
-883,514
-79% -$14.1M ﹤0.01% 3100
2018
Q1 		$18.2M Sell
1,117,606
-231,679
-17% -$3.71M 0.01% 1195
2017
Q4 		$17.3M Sell
1,349,285
-1,449,940
-52% -$16.5M 0.01% 1255
2017
Q3 		$34.4M Buy
2,799,225
+1,805,347
+182% +$16.8M 0.03% 740
2017
Q2 		$8.32M Buy
993,878
+25,308
+3% +$207K 0.01% 1603
2017
Q1 		$8.66M Buy
968,570
+907,620
+1,489% +$9.66M 0.01% 1548
2016
Q4 		$536K Sell
60,950
-856,115
-93% -$6.3M ﹤0.01% 4790
2016
Q3 		$6.19M Sell
917,065
-861,696
-48% -$3.33M 0.01% 1770
2016
Q2 		$6.33M Buy
+1,778,761
New +$5.8M 0.01% 1628
2016
Q1 		– Sell
-453,393
Closed -$1.36M – 8584
2015
Q4 		$1.91M Buy
453,393
+256,897
+131% +$1.17M ﹤0.01% 2799
2015
Q3 		$896K Sell
196,496
-18,786
-9% -$111K ﹤0.01% 3961
2015
Q2 		$1.55M Sell
215,282
-78,835
-27% -$582K ﹤0.01% 3359
2015
Q1 		$2.17M Buy
294,117
+269,148
+1,078% +$1.92M ﹤0.01% 2966
2014
Q4 		$118K Buy
24,969
+10,552
+73% +$41.7K ﹤0.01% 6510
2014
Q3 		$51K Sell
14,417
-139,748
-91% -$551K ﹤0.01% 6897
2014
Q2 		$703K Buy
154,165
+146,625
+1,945% +$606K ﹤0.01% 3937
2014
Q1 		$35K Sell
7,540
-31,139
-81% -$157K ﹤0.01% 7003
2013
Q4 		$194K Sell
38,679
-131,907
-77% -$718K ﹤0.01% 5057
2013
Q3 		$1.06M Sell
170,586
-354,113
-67% -$2.1M ﹤0.01% 3043
2013
Q2 		$2.38M Buy
+524,699
New +$2.82M ﹤0.01% 2329

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Citadel Advisors's ARRY Position: Q3 2019 in Review

Citadel Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 4,346,050 shares — an estimated $201M sold.

Citadel Advisors first reported a position in ARRY in Q2 2013 and held it in 24 quarters. The position peaked at $201M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Citadel Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Citadel Advisors sold 4,346,050 Array Biopharma Inc shares in Q3 2019, an estimated $201M.
  • Citadel Advisors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 24 quarters.
  • Citadel Advisors's Array Biopharma Inc position peaked at $201M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Citadel Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.